(DNDN) Community Analysis from
Bulls REASONS TO BUY
|
93%
agree
31 votes
|
U.S. health regulators amend trial design of Provenge |
|
66%
agree
3 votes
|
Strangle DNDN |
Bears REASONS TO SELL
May 24, 2013
(Investment Underground » Page n...,
7/12/12)
by Ramu Iyer
Dendreon (DNDN) continues to be the subject of much debate and controversy about its future growth prospects. Market sentiment has soured, the stock is down...(read more)
(Value Investing,
5/9/12)
The market has been going through a bit of a rough patch in the last few weeks, especially after France and Greece jumped to the far Left. Greece voted in Communists and neo-Nazis while France...(read more)
(Stock Blog Hub,
3/5/12)
Dendreon Corporation (DNDN) reported fourth-quarter 2011 earnings (including stock-based compensation expense but excluding other special items) of 37 cents per share, in contrast...(read more)
Dendreon (DNDN) Company Overview
There is no analysis for DNDN yet. But you can go to Wikinvest to help create one!
What's in this DNDN analysis on Wikinvest...
